Home >
Dr Sateesh Belemkar

Dr Sateesh Belemkar

Professor

Dr Sateesh Belemkar studied B Pharm (1994, Gulbarga University), M Pharm (1997, Karnatak University) and Ph.D (2010, NMIMS University) from reputed Institutions. He is having vast experience in teaching subjects of Anatomy & Physiology, Pathophysiology and Pharmacology & Toxicology to UG & PG. He is having expertise in handling Industrial toxicity projects and associated with pharmaceutical industries as consultant (project worth 75 lacs completed & a project worth 6.5 lacs is ongoing). He has conducted clinical study of antidiabetic formulations as a part of Ph D studies & registered with CTRI. He is a CPCSEA nominated member and actively involved in IAEC activities. Two students successfully completed Ph.D under his guidance and two more students studies are in progress. He has guided more than 45 PG students for their major projects and 30 students for minor projects. Two of his research observations are awarded with Australian Patent (2021). He presented papers at national and international conferences (36 numbers) and published research articles (54 numbers) in journals of repute. He presented research papers at APPS conference held in Los Angeles in 2009 & BIT’s conference held in Beijing China in 2012, received travel grants from DST & ICMR. He has received many awards and accolades for his research presentations.

Specialization:

Pharmacology
M. Pharm., Ph.D.

Interest areas:

Diabetes, Inflammation & Toxicity studies

Research

·Publications – Total number (International- 34, National- 10)

·Book Chapters- 01

·Presentations- Total number (International- 34, National- 10)

·Research Grants:

Industry projects

Completed: 04

· Toxicity study of 6 new drug formulations of Lupin Ltd, Mumbai, project fund Rs.3lakhs. (Completed, 2010-2012)

· Toxicity study of 10 new drug formulations of Research & Regulatory Services, Thane, project fund Rs.2.5 lakhs. (Completed, 2013-2015)

· Consultancy services for 10 toxicity studies of Research & Regulatory Services, Mumbai, worth Rs. 1 lakh carried out. (Completed, 2013-2015)

· Toxicity study of 11 new drug formulations of Ajanta Pharma Ltd Mumbai, project fund Rs. 30 lakhs. (completed 2015-2018)

 

Ongoing: 02

·Toxicity study of Opthalmic preparations of Ajanta Pharma Ltd Mumbai, project fund Rs. 3.0 lakhs (Ongoing 2019 onwards)

·Safety & efficacy study of herbal formulations of Lupin Ltd Mumbai, project fund Rs. 0.73 lakhs (Ongoing 2019 onwards)

Conferences/Workshops/Seminars attended- 18

Academic activities

He has guided 42 no. of M.Pharm. students for their research projects.

Three candidates are registered under his supervision for PhD.

Awards

·Awarded 1st prize for scientific poster presentation on Modulatory effect of Lagenaria sicenaria fruit extract on prediabetic condition in Wistar rats in PCI sponsored Natioanal seminar held in Aurobindo Institute of Pharmacy Indore on 15th Feb 2020.

·Awarded 2nd prize for scientific poster presentation on Study of Glycyrrhiza glabra on glucose uptake mechanism in rats in IPA Convention Indore 2011.

Professional Memberships

·Life member of Indian Pharmaceutical Association (IPA)

·Life member of Association of Pharmaceutical teachers of India (APTI)

·Life member of Pharmacological Society of India (IPSCON)

·Member, Board of Studies, SVKM’s NMIMS, Mumbai.

Recent Publications

·Lalit Birari, Shivani Wagh. · Kalpesh R. Patil, Umesh B. Mahajan, Banappa Unger, Sateesh Belemkar, Sameer N. Goyal, Shreesh Ojha, Aloin alleviates ‑induced doxorubicin cardiotoxicity in rats by abrogating oxidative stress and pro‑inflammatory cytokines. Cancer Chemotherapy and Pharmacology, 2020, 86,419–426.

·Roopali Agrawal,Sateesh Belemkar, Chandrakant Bonde. Supercritical fluid chromatography versus liquid chromatography for the enantiomeric separation of itraconazole. Microchemical Journal, 2020, 158, 105320.

·Lalit A Birari, Umesh B Mahajan, Kalpesh R Patil, Dipak D Patil, Neha A Bagul, Sateesh Belemkar, Sameer N Goyal, Shreesh Ojha, Chandragouda R Patil. Aloin protects against arsenic trioxide–induced myocardial membrane damage and release of inflammatory cytokines. Naunyn-Schmiedeberg's Archives of Pharmacology, 2020, 393,1365–1372.

·Roopali Agrawal, Dr Sateesh Belemkar and Dr C G Bonde. A Stepwise Strategy Employing Automated Screening for Reversed-Phase Chromatographic Separation of Itraconazole and Its Impurities. Chromatographia, 2019, 82, 1767–1775.

·Shreesh Ojha and Chandragouda R. Patil Kalpesh R. Patil, Umesh B. Mahajan, Banappa S. Unger, Sameer N. Goyal, Sateesh Belemkar, Sanjay J. Surana. Animal models of inflammation for screening of anti-inflammatory drugs: implications for the discovery and development of phytopharmaceuticals. International journal of molecular sciences, 2019, 20(18), 4367.

 

© Copyright 2022. Shri Vile Parle Kelavani Mandal (SVKM) All Rights Reserved.   Disclaimer  |  Privacy Policy
TOP